Loading...
Market
Will a participant in Neuralink's trial regain significant arm mobility by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Trial results published by Neuralink or verified by independent medical journals
Story
Elon Musk's Neuralink Launches Trial for N1 Implant to Control Assistive Robotic Arm
Nov 25, 2024, 06:14 PM
Neuralink, the brain-computer interface (BCI) company founded by Elon Musk, has announced the approval and launch of a new feasibility trial. The trial will test the use of Neuralink's N1 Implant to control an assistive robotic arm. This marks an important first step in the development of brain-computer interfaces, with the potential to restore both digital and physical freedom for individuals with disabilities.
View original story
Similar markets
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
Yes • 50%
No • 50%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful • 25%
Trial halted • 25%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful due to technical issues • 25%
Unsuccessful due to patient complications • 25%
